Evidence map›Paper›PMID 25201001›Full record

ReviewJournal of endocrinological investigation2014

Functional hypothalamic amenorrhea and its influence on women's health.

B Meczekalski, K Katulski, A Czyzyk, A Podfigurna-Stopa, M Maciejewska-Jeske

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of endocrinological investigation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 4 pooled it
8.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 4 syntheses or guidelines pooled it, 156 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Observational
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Menstrual Dysfunction in Adolescent Female Athletes.Sports (Basel, Switzerland) · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

B MeczekalskiDepartment of Gynecological Endocrinology, Poznan University of Medical Sciences, Poznan, Poland, blazejmeczekalski@yahoo.com.
K Katulski
A Czyzyk
A Podfigurna-Stopa
M Maciejewska-Jeske
Poznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFunctional hypothalamic amenorrhea (FHA) is one of the most common causes of secondary amenorrhea. There are three types of FHA: weight loss-related, stress-related, and exercise-related amenorrhea. FHA results from the aberrations in pulsatile gonadotropin-releasing hormone (GnRH) secretion, which in turn causes impairment of the gonadotropins (follicle-stimulating hormone and luteinizing hormone). The final consequences are complex hormonal changes manifested by profound hypoestrogenism. Additionally, these patients present mild hypercortisolemia, low serum insulin levels, low insulin-like growth factor 1 (IGF-1) and low total triiodothyronine.

aimThe aim of this work is to review the available data concerning the effects of FHA on different aspects of women's health.

resultsFunctional hypothalamic amenorrhea is related to profound impairment of reproductive functions including anovulation and infertility. Women's health in this disorder is disturbed in several aspects including the skeletal system, cardiovascular system, and mental problems. Patients manifest a decrease in bone mass density, which is related to an increase in fracture risk. Therefore, osteopenia and osteoporosis are the main long-term complications of FHA. Cardiovascular complications include endothelial dysfunction and abnormal changes in the lipid profile. FHA patients present significantly higher depression and anxiety and also sexual problems compared to healthy subjects.

conclusionsFHA patients should be carefully diagnosed and properly managed to prevent both short- and long-term medical consequences.

Indexed as

Women's HealthAmenorrheaAnimalsFemaleFollicle Stimulating HormoneGonadotropin-Releasing HormoneHumansHypothalamic DiseasesLuteinizing HormoneOsteoporosisReproductionFollicle Stimulating HormoneGonadotropin-Releasing HormoneLuteinizing Hormone

Identifiers

PMID25201001
PMCPMC4207953
OpenAlexW1990840536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.